Related Experiment Video
Updated: Jul 13, 2026
13:01
Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
[Auto-antibodies in liver disease]
Aldo J Montaño Loza1, Paul Angulo
1Division of Gastroenterology and Hepatology, Mayo Clinic, College of Medicine, 200 First Street S.W., Rochester, Minnesota 55905, USA. montanoloza.aldo@mayo.edu
Revista De Gastroenterologia De Mexico
|August 10, 2007
Summary
Autoantibodies in liver disease are diagnostic markers, not causes. New autoantibodies can enhance diagnostic accuracy and guide treatment for better liver disease management.
Area of Science:
- Immunology
- Hepatology
- Autoimmunity
Context:
- Autoantibodies are indicators of immune reactivity in liver conditions.
- They are consequences of liver injury, not the cause.
- Established autoantibodies aid in liver disease categorization.
Purpose:
- To clarify the role of autoantibodies in liver diseases.
- To highlight the diagnostic utility versus etiological significance of autoantibodies.
- To emphasize the need for new autoantibody discoveries.
Summary:
- Autoantibodies are nonpathogenic manifestations of immune responses in liver diseases, serving as diagnostic tools rather than etiological markers.
- Conventional autoantibodies include antinuclear, smooth muscle, liver/kidney microsome type 1, antimitochondrial, and perinuclear antineutrophil cytoplasmic antibodies.
- Diagnosis and treatment do not solely rely on these serological markers, as antibody titers vary and may not correlate with disease activity, with over-interpretation being a common pitfall.
Impact:
- Improved diagnostic precision for liver diseases.
- Identification of new diagnostic parameters and autoantigens.
- Enhanced management strategies for liver conditions through better understanding of autoantibody roles.
Related Concept Videos
01:17Gastritis-II: Pathophysiology
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...